Short Interest in Palisade Bio, Inc. (NASDAQ:PALI) Declines By 34.8%

Palisade Bio, Inc. (NASDAQ:PALI – Get Rating) was the target of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 116,600 shares, a decrease of 34.8% from the January 31st total of 178,900 shares. Currently, 1.0% of the company’s stock are sold short. Based […]

Related Keywords

,Northern Trust Corp ,Geode Capital Management ,Virtu Financial ,Palisade Bio Company Profile Get Rating ,Citadel Advisors ,Nasdaq ,Palisade Bio Inc ,Palisade Bio ,Get Rating ,Trust Corp ,Capital Management ,State Street Corp ,Sbio Company Profile ,Nasdaq Pali ,Upali ,Medical ,Stocks ,Options ,Put ,Call ,